Local activation of cannabinoid CB(1 )receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents

BACKGROUND: Systemic administration of cannabinoid agonists is known to reduce pain induced by bladder inflammation and to modulate cystometric parameters in vivo. We have previously reported that intravesical administration of a cannabinoid agonist reduces the electrical activity of bladder afferen...

Descripción completa

Detalles Bibliográficos
Autores principales: Walczak, Jean-Sébastien, Cervero, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115893/
https://www.ncbi.nlm.nih.gov/pubmed/21554718
http://dx.doi.org/10.1186/1744-8069-7-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115893/
https://www.ncbi.nlm.nih.gov/pubmed/21554718
http://dx.doi.org/10.1186/1744-8069-7-31

Ejemplares similares